Ipamorelin research overview

Compound identity and classification

Ipamorelin is classified as: Pentapeptide ghrelin receptor (GHS-R1a) agonist.

Ipamorelin is a synthetic pentapeptide containing non-natural residues, including aminoisobutyric acid and D-amino acids, that confer resistance to enzymatic degradation relative to native ghrelin.

General research background

Laboratory literature characterizes Ipamorelin primarily by its selectivity: preclinical reports describe growth hormone release in animal and cell models without the broader endocrine cross-activation seen with earlier secretagogues. These are model-system findings only.

Molecular and biological pathways under investigation

Research centers on GHS-R1a, a Gq-coupled receptor, and the phospholipase C / inositol trisphosphate / intracellular calcium cascade associated with somatotroph secretory granule release.

Areas of laboratory research

Reported laboratory work with this material clusters into the following areas. Listing an area describes where research activity exists, not an established result.

• Receptor selectivity panels across endocrine GPCRs
• Calcium flux and secretion assays in pituitary cell lines
• Comparative secretagogue potency studies
• Peptide stability studies of non-natural residue substitution

Analytical documentation

ATMI Labs publishes the identity and purity documentation supplied for each released lot. Any purity figure shown comes from the report filed for that specific batch rather than from a general catalog claim.

Research limitations

Published work involving Ipamorelin is largely confined to in vitro systems and preclinical animal models. Findings in those systems do not establish effects in humans, and model-to-model variability in preparation, vehicle, and endpoint selection limits direct comparison between studies.

Analytical purity describes the material, not biological activity. Laboratories should design their own controls, and treat any pathway description as a hypothesis under investigation rather than an established result.

Handling and laboratory considerations

Lyophilized research materials are handled as temperature-sensitive laboratory chemicals. Storage temperature, reconstitution solvent, container choice, and stability windows are determined by the receiving laboratory's written protocol.

Every ATMI Labs lot is released with batch documentation so identity and purity figures used in a study can be traced back to the specific lot in hand.

• Confirm the lot identifier on the vial label against the published quality record.
• Record lot, strength, and receipt date in the laboratory inventory before use.
• Follow institutional handling, labeling, and disposal procedures for research chemicals.

References and scientific sources

ATMI Labs does not summarize or reinterpret individual studies on this page. Laboratories designing work with this material are expected to consult the primary literature directly.

• PubMed / MEDLINE (National Library of Medicine) for peer-reviewed primary literature.
• PubChem and ChEMBL for chemical identity, structure, and physicochemical records.
• UniProt for sequence and receptor/target annotation where a protein target applies.
• The lot-specific quality record published by ATMI Labs for analytical identity and purity.

Research use scope

Ipamorelin supplied by ATMI Labs is sold exclusively for laboratory research and analytical purposes. It is not a drug, supplement, cosmetic, or food, and it is not intended for human or veterinary use.

Nothing on this page describes therapeutic use, dosing, or clinical outcomes. Literature referenced in general terms describes laboratory and preclinical model systems only.